Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
3.190
+0.010 (0.31%)
At close: Oct 29, 2024, 4:00 PM
3.250
+0.060 (1.88%)
After-hours: Oct 29, 2024, 7:57 PM EDT
Codexis Market Cap
Codexis has a market cap or net worth of $226.26 million as of October 29, 2024. Its market cap has increased by 62.89% in one year.
Market Cap
226.26M
Enterprise Value
195.59M
1-Year Change
62.89%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since April 22, 2010, Codexis's market cap has decreased from $449.60M to $226.26M, a decrease of -49.68%. That is a compound annual growth rate of -4.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 225.50M | 5.87% |
| Dec 29, 2023 | 213.00M | -30.41% |
| Dec 30, 2022 | 306.10M | -84.91% |
| Dec 31, 2021 | 2.03B | 56.76% |
| Dec 31, 2020 | 1.29B | 38.30% |
| Dec 31, 2019 | 935.70M | 3.72% |
| Dec 31, 2018 | 902.10M | 123.46% |
| Dec 29, 2017 | 403.70M | 112.92% |
| Dec 30, 2016 | 189.60M | 11.20% |
| Dec 31, 2015 | 170.50M | 71.01% |
| Dec 31, 2014 | 99.70M | 87.05% |
| Dec 31, 2013 | 53.30M | -35.78% |
| Dec 31, 2012 | 83.00M | -56.43% |
| Dec 30, 2011 | 190.50M | -47.49% |
| Dec 31, 2010 | 362.80M | -19.31% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 231.15M |
| Trevi Therapeutics | 230.84M |
| Kyverna Therapeutics | 229.54M |
| Instil Bio | 229.52M |
| ProKidney | 225.63M |
| Pyxis Oncology | 225.21M |
| Solid Biosciences | 225.01M |
| CVRx, Inc. | 224.17M |